+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Fertility outcome of infertile women with adenomyosis treated with the combination of a conservative microsurgical technique and GnRH agonist: long-term follow-up in a series of nine patients



Fertility outcome of infertile women with adenomyosis treated with the combination of a conservative microsurgical technique and GnRH agonist: long-term follow-up in a series of nine patients



Taiwanese Journal of Obstetrics and Gynecology 51(2): 212-216



This paper reports the long-term follow-up (62-83 months) of women with unexplained subfertility secondary to severe adenomyosis treated with the combination of conservative surgery and gonadotropin releasing hormone agonist (GnRH agonist) therapy. A retrospective study included nine patients with a history of > 3 years of unexplained infertility who had extensive uterine adenomyosis. These nine couples were diagnosed with unexplained infertility after excluding other possible causes, such as the male factor, ovulation disorders, structural abnormality, and infections. All were essentially normal except for presumed uterine adenomyosis and elevated serum levels of CA125. All underwent a careful excision of the adenomyosis tissue using a microsurgical technique, and then a six-month course of GnRH agonist therapy. The outcome evaluations included serum level of CA125, degree of dysmenorrhea, and rate of spontaneous pregnancy. Postoperative follow-up showed that the severity of dysmenorrhea was significantly improved. The improvement scale was positively correlated with a decline in the serum level of CA125. A postoperative serum CA125 decreased to less than 10.00 IU/mL predicted well the spontaneous pregnancy rate, especially during the therapy. In the end, only two women became pregnant and finally delivered viable babies in this study. Although the combination of careful conservative surgery and GnRH agonist therapy might provide some benefits in patients with unexplained infertility and presumed severe adenomyosis, two-thirds of the patients still failed to become pregnant. The postoperative serum level of CA125 could predict the future pregnancy rate.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 036493159

Download citation: RISBibTeXText

PMID: 22795096

DOI: 10.1016/j.tjog.2012.04.008


Related references

Treatment of infertile women with adenomyosis with a conservative microsurgical technique and a gonadotropin-releasing hormone agonist. Fertility and Sterility 73(5): 1061-1062, 2000

Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate. Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate (Suprecur), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome. European Journal of Obstetrics and Gynecology and Reproductive Biology 73(2): 153-160, 1997

Long-term follow-up on the treatment of endometriosis with the GnRH-agonist buserelinacetate Long-term follow-up data of 42 patients with endometriosis who were treated with GnRH-agonist buserelinacetate , were evaluated in respect of recurrence of pain symptoms and pregnancy outcome. European Journal of Obstetrics and Gynecology and Reproductive Biology 73(2): 153-160, 1997

Flexible GnRH antagonist protocol vs. long GnRH agonist protocol in patients with polycystic ovary syndrome treated for IVF: comparison of clinical outcome and embryo quality. Ginekologia Polska 87(4): 265-270, 2016

Suprasellar meningiomas--neurological and visual outcome at long-term follow-up in a homogeneous series of patients treated microsurgically. Acta Neurochirurgica 140(12): 1231-1238, 1998

Ovarian suppression with gnrh agonist or danazol combined with conservative surgery in infertile women with extensive endometriosis reduction in the size of ovarian endometriomas. The American Fertility Societytific Papers To Be Presented At The 43rd Annual Meeting Of The American Fertility Society, Reno, Nevada, Usa, September 28-30,: Birmingham, Alabama, Usa. Paper: 111, 1987

Trh gnrh test in acromegaly a long term follow up of successfully treated patients. Journal of Endocrinological Investigation 14(6 Suppl. 4): 55, 1991

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Human Reproduction 16(4): 644-651, 2001

Long-term suppression of fertility in female giraffe using the GnRH agonist deslorelin as a long-acting implant. Theriogenology 66(2): 431-438, 2006

TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients. Hormone and Metabolic Research 25(5): 275-277, 1993

Long-term follow-up of severely symptomatic women with adenomyoma treated with combination therapy. Taiwanese Journal of Obstetrics and Gynecology 52(1): 85-89, 2013

Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles. Clinical and Experimental Reproductive Medicine 39(4): 166-171, 2012

Outcome from consecutive ICSI cycles in patients treated with recombinant human LH and those supplemented with urinary hCG-based LH activity during controlled ovarian stimulation in the long GnRH-agonist protocol. Gynecological Endocrinology 29(5): 430-435, 2013

Use of GnRH agonist implants for long-term suppression of fertility in extensively managed heifers and cows. Animal Reproduction Science 74(3/4): 151-162, 2002

Extended long-term down-regulation with GnRH agonist improves IVF outcome. Human Reproduction 14(ABSTR BOOK 1): 307, 1999